Results 11 to 20 of about 23,984 (264)

Antiemetic Strategies in Patients Who Undergo Hematopoietic Stem Cell Transplantation

open access: yesClinical Hematology International, 2022
Hematopoietic stem cell transplantation (HSCT) is an integral part of the treatment strategy in patients with a hematological disorder. Chemotherapy-induced nausea and vomiting (CINV) is still an issue in patients who undergo HSCT.
Sayako Yuda   +3 more
doaj   +2 more sources

How to manage the initiation of apomorphine therapy without antiemetic pretreatment: A review of the literature [PDF]

open access: yesClinical Parkinsonism & Related Disorders, 2023
Introduction: Pretreatment with the antiemetic trimethobenzamide has been recommended practice in the United States (US) to address the risk of nausea and vomiting during initiation of apomorphine treatment.
Stuart H. Isaacson   +3 more
doaj   +3 more sources

A retrospective review of treatment patterns of antiemetic agents for chemotherapy-induced nausea and vomiting

open access: yesSAGE Open Medicine, 2018
Objectives: To evaluate the treatment pattern of antiemetic agents used for chemotherapy-induced nausea and vomiting in a tertiary hospital in Saudi Arabia. Methods: Over a period of 7 weeks, all new chemotherapy order sheets were collected and evaluated
Abdulrahman Alamri   +3 more
doaj   +3 more sources

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Analysis of Antiemetic Use After Initiation of Hormone Therapy [PDF]

open access: yes, 2022
This cross-sectional study investigates the occurrence of the prescribing cascade of antiemetic after hormone ...
Lund, Lars Christian; id_orcid   +6 more
core   +1 more source

Cyclic vomiting syndrome (CVS) responsive to single-dose olanzapine: a case report [PDF]

open access: yesExploration of Neuroscience
Cyclic vomiting syndrome (CVS) is a rare disorder in which stereotypical periods of intermittent nausea and vomiting last between hours and over a week.
Sara Sipilä   +4 more
doaj   +1 more source

An Update in Our Understanding of the Relationships Between Gene Polymorphisms and Chemotherapy-Induced Nausea and Vomiting

open access: yesInternational Journal of General Medicine, 2021
Yilan Jin,* Xiaorong Li,* Caihong Jiang,* Jun Zhao, Guang Liu, Hui Li, Gaowa Jin, Quanfu Li Department of Medical Oncology, Ordos Central Hospital, Ordos, 017000, People’s Republic of China*These authors contributed equally to this ...
Jin Y   +7 more
doaj  

Effect of 5% Dextrose Infusion on Postoperative Nausea and Vomiting in Patients undergoing Laparoscopic Cholecystectomy: A Randomised Controlled Study [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Introduction: Postoperative Nausea and Vomiting (PONV) is defined as nausea, vomiting, or retching occurring in the postanaesthesia care unit within the first 24 hours of postoperative period. It is most common following laparoscopic cholecystectomy,
BR Lakshmi   +2 more
doaj   +1 more source

Monitoring the adherence to an adapted evidence-based clinical practice guideline on antiemetics in 669 patients with cancer receiving 1451 chemotherapy doses at a University oncology center in Saudi Arabia

open access: yesJournal of Nature and Science of Medicine, 2021
Objectives: Chemotherapy-induced nausea and vomiting (CINV) is a common medication safety issue among cancer patients worldwide. However, there remains a research gap on adherence to the clinical practice guidelines (CPGs) for antiemetic medications to ...
Haya Fahad Al-Salloum   +2 more
doaj   +1 more source

Antiemetic therapy in Asia Pacific countries for patients receiving moderately and highly emetogenic chemotherapy-a descriptive analysis of practice patterns, antiemetic quality of care, and use of antiemetic guidelines

open access: yes, 2017
This paper reports prescribing patterns for prophylaxis of chemotherapy-induced nausea and vomiting (CINV) after highly or moderately emetogenic chemotherapy (HEC or MEC) for cancer in six Asia Pacific countries. ;In a prospective noninterventional study,
Yu, Shiying;Burke, Thomas A.;Chan, Alexandre;Kim, Hoon-Kyo;Hsieh, Ruey Kuen;Hu, Xichun;Liang, Jin-Tung;Banos, Ana;Spiteri, Carmel;Keefe, Dorothy M. K.   +1 more
core   +1 more source

Home - About - Disclaimer - Privacy